KalVista Pharmaceuticals, Inc. (FRA:4XC1)
Germany
· Delayed Price · Currency is EUR 11.40
-0.30 (-2.56%)
At close: Dec 3, 2025
KalVista Pharmaceuticals Revenue
KalVista Pharmaceuticals had revenue of $13.69M USD in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $1.43M.
Revenue (ttm)
$1.43M
Revenue Growth
n/a
P/S Ratio
572.65
Revenue / Employee
$5.28K
Employees
270
Market Cap
713.88M EUR
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |